Devyanshi Dixit: Could a Simple Blood Test Transform Gynecologic Cancer Detection?
Devyanshi Dixit, Program Manager at CLS Event and Publication and Conference Manager at the 12th Global Summit on Gynecology, shared on LinkedIn:
“Could a Simple Blood Test Transform Gynecologic Cancer Detection?
What if a blood sample could reveal clues about cancer before symptoms appear?
It sounds futuristic – but researchers are already exploring ways to detect molecular signals of gynecologic cancers through blood.
The emerging field of liquid biopsy is changing how scientists think about cancer detection.
What Could a Blood Test Look For?
- Circulating Tumor DNA (ctDNA)
Cancer cells can release fragments of DNA into the bloodstream. Detecting and analyzing these molecular changes may provide clues about the presence or characteristics of a tumor.
- Circulating Biomarkers
Researchers are investigating proteins, RNA, methylation patterns, and other molecular signatures that could help distinguish cancer-related changes.
- AI + Multi-Omics
Combining molecular data with artificial intelligence may help identify complex patterns that are difficult to detect using a single biomarker.
- Earlier Detection and Monitoring
Liquid biopsy is being studied not only for detection, but also for monitoring treatment response and identifying molecular changes associated with recurrence.
But Here’s the Catch
A promising blood test is not automatically a reliable screening test.
So, Could Blood Become the Next Window Into Cancer?
Potentially.
Imagine a future where a minimally invasive blood test could complement existing approaches and help identify women who need earlier, more targeted investigation.
That could change the pathway from:
Symptoms – Diagnosis
to potentially:
Molecular Signal – Risk Assessment – Targeted Investigation – Earlier Detection
The 12th Global Summit on Gynecology, Fertility and Women’s Health (GFWH 2026) brings together experts exploring advances in gynecologic oncology, precision medicine, molecular diagnostics, AI, and emerging technologies in women’s healthcare.
- November 23–24, 2026
- Bangkok, Thailand
The next clue to gynecologic cancer may not come from a scan.
It may come from the bloodstream.”
Other articles featuring Devyanshi Dixit on Fertility News.
-
Sep 1, 2026, 17:04Marco Zaccaria: Catherine Whittington Is Launching a New Project to Develop Uterine Fibroid Models
-
Sep 1, 2026, 17:02Vida Shafti: Why Does Women’s Infertility Require a 360° Perspective?
-
Sep 1, 2026, 16:59Brian A. Levine: 18 Months Just to Match with a Surrogate, Not to Start the Journey
-
Sep 1, 2026, 16:57Amos Grünebaum: The Riskiest Day of Pregnancy Is the Day Everyone Stops Watching
-
Sep 1, 2026, 16:55Natasha Mamdani: Pregnancy Provides a Unique Window into a Woman’s Future Cardiovascular Health
-
Sep 1, 2026, 16:51Devyanshi Dixit: Is Hormonal Aging Modifiable?
-
Sep 1, 2026, 16:44Updated Patient Safety Guidelines on Infection Prevention in Ultrasound Examinations – SMFM
-
Sep 1, 2026, 16:32Nitiz Murdia: A Junior Embryologist Who Stays Quiet Is a Bigger Risk, Than One Who Flags Uncertainty
-
Sep 1, 2026, 16:28September Is Gynaecologic Cancer Awareness Month – European Society of Gynaecological Oncology